DS Healthcare Group Launches Brazilian E-Commerce Site to Support Sales Momentum in Fast Growing Beauty Market
Products ideally suited for Brazil's $43 billion beauty industry
Pompano Beach, Sept. 11, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX), a leading developer of
personal care products, today announced it has launched its
Brazilian website: http://dslabshop.com.br. The
e-commerce site provides convenient online shopping for Brazilians.
The site also offers extensive product information to support
in-stores sales of its products.
DS Healthcare recently expanded the distribution of its products
into Brazil's CSB Drogaria which operates two retail pharmacy
chains, Drogasmil and Farmalife with stores primarily located in
the Rio de Janeiro metropolitan area.
"Our new e-commerce site in Brazil reaches the country's broader
population. Our 10 best-selling SKUs approved for commercialization
are currently being sold in the Brazilian market through retail
stores in one key metropolitan area and we expect our national
reach through e-commerce will further increase exposure and sales
of our products," stated DS Healthcare President and CEO Daniel
Khesin. "We've seen through our initial pilot programs that our
product line, particularly our hair growth products are ideally
suited for the Brazilian consumer."
According to Euromonitor, a market research firm, the Brazilian
beauty industry generated $43 billion in sales in 2011, an increase of 19% over the prior
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development and
distribution of topical therapies for personal care, including what
management believes is the world's most effective topical treatment
for hair loss. Its products are sold through a network of salons,
pharmacies, online retailers, specialty retailers and select
department stores. Its brands include DS Laboratories(www.DSLaboratories.com), Sigma Skin (www.(www.SigmaSkin.com), Polaris Research
Laboratories (www.PolarisResearchLabs.com) The Pure
Guild (www.ThePureGuild.com) and Nutra
Except for statements of historical fact, the matters discussed
in this press release are forward-looking and made pursuant to the
Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. "Forward-looking statements" describe future
expectations, plans, results, or strategies, and are generally
preceded by words such as "future," "plan" or "planned," "expects,"
or "projected." These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many
of which are beyond the company's control that may cause actual
results to differ materially from stated expectations. These risk
factors include, among others, limited operating history,
difficulty in developing and marketing products, intense
competition, and additional risks factors as discussed in reports
filed by the company with the Securities and Exchange Commission,
which are available at http://www.sec.gov.
Source: DS Healthcare Group,Inc.